Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.
Lian
Jiamei
J
Huang
Xu-Feng
XF
Pai
Nagesh
N
Deng
Chao
C
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000188:drug therapy*; D002648:Child; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D009765:Obesity / Q000139:chemically induced*; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole